HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natural immunity in cats to feline leukemia viral antigens.

Abstract
An isotopic antiglobulin assay was developed to measure antibodies in "normal" cats to FOCMA, a cell surface antigen associated with immunity to FeLV-induced tumors. The assay was shown to be specific for detecting FOCMA antibody by several criteria including a correlation with cell membrane immunofluorescence and absorption tests. Antibody to FOCMA developed following FeLV infection and was expressed in heterologous species. In combination with an assay for antibody to FeLV p30, the major virion structural protein, 200 cats sera from three different geographic areas were examined for evidences of FeLV-type-C-virus infection. Approximately 17% of all sera examined contained antibody to FOCMA. Antibodies directed to the FeLV p30 were detected in 8 of the sera and only in cats with FOCMA antibody. The correlation in cat sera between antibody to FOCMA and FeLV p30 antigen suggests that both are associated with the same process, infection with FeLV type-C-virus. The relationship of the observed pattern of antibody response is discussed in relation to other horizontally transmitted RNA-containing viruses.
AuthorsS K Ruscetti, W P Parks
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 117 Issue 5 Pt.2 Pg. 2029-35 (Nov 1976) ISSN: 0022-1767 [Print] United States
PMID186536 (Publication Type: Journal Article)
Chemical References
  • Antigens, Viral
Topics
  • Animals
  • Antibody Specificity
  • Antigens, Viral
  • Binding Sites, Antibody
  • Callitrichinae
  • Cats
  • Cell Membrane (immunology)
  • Coombs Test
  • Fluorescent Antibody Technique
  • Haplorhini
  • Immunity
  • Leukemia Virus, Feline (immunology)
  • Leukemia, Experimental (immunology)
  • Virus Diseases (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: